Thursday, August 11, 2022 6:41:45 PM
π $CLNV π This tech is needed badly! Canβt stress enough how big of a deal this is to the π They are scaling this and starting to flip the switches on these plants! I like to have some green plays in the portfolio and @CleanVisionCorp is great option near bottom! DD Nowπ₯ππ₯ pic.twitter.com/SKQ0aY114a
— Nickeli (@nickeli54) August 11, 2022
Recent CLNV News
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 03/08/2024 09:30:16 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 02/16/2024 10:01:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals β’ Edgar (US Regulatory) β’ 02/14/2024 04:01:56 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 01/23/2024 09:31:49 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] β’ Edgar (US Regulatory) β’ 12/15/2023 09:57:57 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 12/12/2023 10:03:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] β’ Edgar (US Regulatory) β’ 11/14/2023 09:54:03 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 10/03/2023 08:59:55 PM
- Form EFFECT - Notice of Effectiveness β’ Edgar (US Regulatory) β’ 09/26/2023 04:15:31 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] β’ Edgar (US Regulatory) β’ 09/20/2023 08:15:48 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] β’ Edgar (US Regulatory) β’ 09/15/2023 09:29:32 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 β’ Edgar (US Regulatory) β’ 08/31/2023 01:59:28 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] β’ Edgar (US Regulatory) β’ 08/21/2023 09:23:35 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB β’ Edgar (US Regulatory) β’ 08/14/2023 07:48:13 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 08/08/2023 07:14:10 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 07/10/2023 07:39:44 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 06/29/2023 05:27:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon β’ NNVC β’ May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update β’ ILUS β’ May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm β’ AVAI β’ May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company β’ BANT β’ May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia β’ BLO β’ Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 β’ HYDI β’ Apr 29, 2024 9:10 AM